samedi 19 juillet 2014

Cannabis, schizophrenia, genomics and the complexity of disease

Molecular Psychiatry advance online publication 24 June 2014; doi: 10.1038/mp.2014.51

Genetic predisposition to schizophrenia associated with increased use of cannabis

R A Power1,2, K J H Verweij3, M Zuhair1, G W Montgomery4, A K Henders4, A C Heath5, P A F Madden5, S E Medland4, N R Wray2 and N G Martin4

  1. 1MRC Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, London, UK
  2. 2Queensland Brain Institute, The University of Queensland, St Lucia, QLD, Australia
  3. 3Department of Developmental Psychology and EMGO Institute for Health and Care Research, VU University, Amsterdam, The Netherlands
  4. 4QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia
  5. 5Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA

Correspondence: R Power, MRC Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, King’s College London, DeCrespigny Park, Denmark Hill, London SE5 8AF, UK. E-mail: robert.r.power@kcl.ac.uk


http://www.nature.com/mp/journal/vaop/ncurrent/abs/mp201451a.html